1
Bhagat Hitesh R, Donovan Joanne M, Braunlin William, Sacchiero Robert: Enteric coated aliphatic amine polymer bile acid sequestrants. Genzyme Corporation, Bhagat Hitesh R, Donovan Joanne M, Braunlin William, Sacchiero Robert, DAVIS Steven G, July 21, 2005: WO/2005/065291 (32 worldwide citation)

Tablets, capsules, sachets, or papers having one or more aliphatic amine polymers allow for the targeted release of the polymers at a specific region of the gastrointestinal tract, especially the small intestine. These tablets, capsules, sachets, or papers are useful in a method for lowering cholest ...


2
Bhagat Hitesh R, Goldberg Jeffrey M: Sachet formulation for amine polymers. Genzyme Corporation, Bhagat Hitesh R, Goldberg Jeffrey M, BECK Christopher M, March 29, 2007: WO/2007/035313 (3 worldwide citation)

A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a sub ...


3
Bhagat Hitesh R, Goldberg Jeffrey M: Sachet formulation for amine polymers. Genzyme, May 28, 2008: EP1924246-A2 (1 worldwide citation)

A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a sub ...


4
Bhagat Hitesh R, Goldberg Jeffrey M: Sachet formulation for amine polymers. Genzyme, guoxiao dong, September 24, 2008: CN200680034071

A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a sub ...


5
Ho Chris, Chawla Jugminder, Bhagat Hitesh R: Polystyrene sulfonate polymer tablets, their preparation and use. Genzyme, May 27, 2009: EP2061435-A2

The present invention provides tablets containing at least about 70% of polystyrene sulfonate polymer, binder and moisture. The invention further relates to methods of treating medical conditions including antibiotic-associated diarrhea such as that caused by Chlostridium difficile, comprising admin ...


6
Mhaskar Sunil V, Bhagat Hitesh R, Kurtz Caroline I, Katti Sanjeev S, Chancellor Adams Toni G, Chorghade Mukund S: Poly (potassium and sodium styrene sulfonate), its manufacture and its uses. Genzyme, June 22, 2005: EP1542706-A1

Antibiotic-associated diarrhea, such as that caused by Clostridium difficile, represents a serious medical complication that can result from administering a broadspectrum antibiotic to a subject. Such diarrhea leads to significant potassium loss from the subject. The present invention discloses a po ...


7
Bhagat Hitesh R, Donovan Joanne M, Braunlin William, Sacchiero Robert: Enteric coated aliphatic amine polymer bile acid sequestrants. Genzyme, September 13, 2006: EP1699442-A2

Tablets, capsules, sachets, or papers having one or more aliphatic amine polymers allow for the targeted release of the polymers at a specific region of the gastrointestinal tract, especially the small intestine. These tablets, capsules, sachets, or papers are useful in a method for lowering cholest ...


8
Mhaskar Sunil V, Bhagat Hitesh R, Kurtz Caroline I, Katti Sanjeev S, Chancellor Adams Toni G, Chorghade Mukund S: Poly (potassium and sodium styrene sulfonate), its manufacture and its uses. Genzyme Corporation, Mhaskar Sunil V, Bhagat Hitesh R, Kurtz Caroline I, Katti Sanjeev S, Chancellor Adams Toni G, Chorghade Mukund S, DAVIS Steven G, January 29, 2004: WO/2004/009100

Antibiotic-associated diarrhea, such as that caused by Clostridium difficile, represents a serious medical complication that can result from administering a broad­spectrum antibiotic to a subject. Such diarrhea leads to significant potassium loss from the subject. The present invention discloses a p ...


9
Ho Chris, Chawla Jugminder, Bhagat Hitesh R: Polystyrene sulfonate polymer tablets, their preparation and use. Genzyme Corporation, Ho Chris, Chawla Jugminder, Bhagat Hitesh R, DAVIS Steven G, March 13, 2008: WO/2008/030512

The present invention provides tablets containing at least about 70% of polystyrene sulfonate polymer, binder and moisture. The invention further relates to methods of treating medical conditions including antibiotic-associated diarrhea such as that caused by Chlostridium difficile, comprising admin ...


10